Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,017,642 papers from all fields of science
Search
Sign In
Create Free Account
Alendronate Sodium
Known as:
Alendronic Acid Monosodium Salt Trihydrate
, Alendronate Monosodium Salt, Trihydrate
, sodium alendronate
Expand
The sodium salt of alendronate, a second generation bisphosphonate and synthetic analog of pyrophosphate with bone anti-resorption activity…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Broader (2)
Alendronate
Diphosphonates
Alendronic acid
Alendronic acid 35 MG Oral Tablet
Alendronic acid 70 MG Oral Tablet [Fosamax]
Narrower (2)
Fosamax
MK-217
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Understanding the influence of alendronate on the morphology and phase transformation of apatitic precursor nanocrystals.
Guiling Zhang
,
Rong Huang
,
+7 authors
Z. Gou
Journal of Inorganic Biochemistry
2012
Corpus ID: 12848063
2011
2011
Unusual case of a conservatively treated pathological fracture after sequestrectomy in a patient with long-term oral bisphosphonate use.
S. C. Kuijpers
,
Erik W van Roessel
,
J. V. van Merkesteyn
Journal of cranio-maxillo-facial surgery…
2011
Corpus ID: 37579093
2010
2010
Comparison of the effects of alendronate sodium and calcitonin on bone–prosthesis osseointegration in osteoporotic rats
Bl Chen
,
D. Xie
,
+5 authors
W. Liao
Osteoporosis International
2010
Corpus ID: 9613928
SummaryAlendronate (ALO) and calcitonin (CT), as commonly used antiosteoporosis drugs in current clinical practice, have been…
Expand
2009
2009
HIGH ENCAPSULATION EFFICIENCY OF SODIUM ALENDRONATE IN EUDRAGIT S100/HPMC BLEND MICROPARTICLES
L. Cruz
,
E. Assumpção
,
S. Guterres
,
Raffin Pohlmann
2009
Corpus ID: 56461471
The hydrophilic drug sodium alendronate was encapsulated in blended microparticles of Eudragit® S100 and Methocel® F4M or…
Expand
2008
2008
Development of an oral microemulsion formulation of alendronate: Effects of oil and co-surfactant type on phase behaviour
F. Karamustafa
,
N. Çelebi
Journal of Microencapsulation
2008
Corpus ID: 205520295
This study aimed to prepare a water-in-oil microemulsion formulation of alendronate. Pseudo-ternary phase diagrams were…
Expand
2007
2007
Effects of alendronate sodium therapy on carotid intima media thickness in postmenopausal women with osteoporosis
T. Delibaşı
,
R. Emral
,
M. Erdoğan
,
N. Kamel
Advances in Therapy
2007
Corpus ID: 46569707
Osteoporosis and cardiovascular disease are major health problems that lead to morbidity and mortality. Bisphosphonates are among…
Expand
Highly Cited
2006
Highly Cited
2006
Effect of alendronate on endosseous implant integration: an in vivo study in rabbits.
Guillermo E. Chacon
,
Eric A. Stine
,
Peter E. Larsen
,
F. Beck
,
Edwin A. McGlumphy
Journal of oral and maxillofacial surgery
2006
Corpus ID: 25462057
2002
2002
Inhibition of particulate debris-induced osteolysis by alendronate in a rat model.
P. J. Thadani
,
B. Waxman
,
Eduard H. Sladek
,
R. Barmada
,
Mark H. Gonzalez*
Orthopedics
2002
Corpus ID: 37662556
A rat model was used to study the efficacy of alendronate therapy in inhibition of particle-induced periprosthetic osteolysis. A…
Expand
2001
2001
The effect of alendronate (Fosamax) and implant surface on bone integration and remodeling in a canine model.
Sally R. Frenkel
,
William L. Jaffe
,
+7 authors
P. E. D. Cesare
Journal of Biomedical Materials Research
2001
Corpus ID: 7674946
Patients at high risk for osteoporosis and its associated morbidity, including postmenopausal women, are being pharmacologically…
Expand
2001
2001
Comparison of calcitonin, alendronate and fluorophosphate effects on ovariectomized rat bone.
G. Giavaresi
,
M. Fini
,
+4 authors
R. Giardino
Biomedicine & pharmacotherapy = Biomedecine…
2001
Corpus ID: 22510276
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE